AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics
Home - Financial Times [Unofficial]
June 19, 2026
Buyout comes amid an uptick in biotech dealmaking as Big Pharma seeks to bolster its drug pipelines
Discussion in the ATmosphere